Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
997 INR | +1.36% | -0.85% | +44.67% |
May. 13 | Zydus Lifesciences Gets US FDA Nod to Market Dexamethasone Tablets | MT |
May. 10 | India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.67% | 11.85B | |
+21.28% | 44.4B | |
+24.60% | 23.03B | |
+18.29% | 15.14B | |
+12.87% | 13.12B | |
-8.33% | 6.99B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.22% | 5.52B | |
-6.31% | 4.62B |
- Stock Market
- Equities
- ZYDUSLIFE Stock
- News Zydus Lifesciences Limited
- Jefferies Adjusts Zydus Lifesciences’ Price Target to INR640 From INR630, Keeps at Hold